These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 21731887)
41. Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms. Dhillon S Drugs; 2013 Sep; 73(13):1451-62. PubMed ID: 23881669 [TBL] [Abstract][Full Text] [Related]
42. The role of aldosterone blockers in the management of chronic heart failure. Coca SG; Perazella MA Am J Med Sci; 2005 Oct; 330(4):176-83. PubMed ID: 16234610 [TBL] [Abstract][Full Text] [Related]
44. Aldosterone receptor antagonists and cardiovascular disease: do we need a change of the guard? Jewell CW; Watson LE; Mock J; Dostal DE Cardiovasc Hematol Agents Med Chem; 2006 Apr; 4(2):129-53. PubMed ID: 16611048 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure. George J; Struthers AD Expert Opin Pharmacother; 2007 Dec; 8(17):3053-9. PubMed ID: 18001264 [TBL] [Abstract][Full Text] [Related]
55. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy? Werner C; Pöss J; Böhm M Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830 [TBL] [Abstract][Full Text] [Related]
56. Eplerenone in chronic heart failure with depressed systolic function. Volterrani M; Iellamo F Int J Cardiol; 2015 Dec; 200():12-4. PubMed ID: 26044084 [TBL] [Abstract][Full Text] [Related]
57. Effectiveness and Safety of Aldosterone Antagonist Therapy Use Among Older Patients With Reduced Ejection Fraction After Acute Myocardial Infarction. Wang TY; Vora AN; Peng SA; Fonarow GC; Das S; de Lemos JA; Peterson ED J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796254 [TBL] [Abstract][Full Text] [Related]
58. The risks and benefits of aldosterone antagonists. Sica DA Curr Heart Fail Rep; 2005 Aug; 2(2):65-71. PubMed ID: 16036053 [TBL] [Abstract][Full Text] [Related]
59. Eplerenone for the treatment of cardiovascular disorders. Watanabe M; Krum H Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):831-8. PubMed ID: 22908915 [TBL] [Abstract][Full Text] [Related]
60. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. Pitt B; Remme W; Zannad F; Neaton J; Martinez F; Roniker B; Bittman R; Hurley S; Kleiman J; Gatlin M; N Engl J Med; 2003 Apr; 348(14):1309-21. PubMed ID: 12668699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]